Original Article

Year : 2024

Volume : Volume 15

Issue : Issue 5

Modified Prolotherapy: A Ray of Hope for Temporomandibular Joint Disorders

Dr. Supraja Vemuganti

Address for correspondence :
Dr. Supraja Vemuganti
supraja.vemuganti@gmail.com

Abstract


Background: Temporomandibular joint (TMJ) disorder is one of the most common causes of orofacial pain and dysfunction. Prolotherapy is a promising approach in the management of temporomandibular disorder (TMD), especially in refractory cases where conservative management has failed and in patients where surgical management is not possible. Aims: The aims of the study are to determine the effectiveness of 12.5% dextrose prolotherapy in the management of TMJ disorders. Methods: Patients suffering and diagnosed cases of TMDs were included in the study. Prolotherapy was performed using 12.5% dextrose and 2% lidocaine on the subjects. Results and Conclusion: Data obtained will be subjected to statistical analysis, and a conclusion will be arrived at.